Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2021 Mar 21;28(11):6572–6579. doi: 10.1245/s10434-021-09683-8

Table 4.

Patients with no structural disease and Ct > 200

Variable No LND LND p-value
N = 44 N = 45
Age at Procedure, year median (range) 58 (52–63) 50 (39–60) 0.04
Gender (Female) 23 (52%) 29 (64%) 0.3
Size (cm), median (range) 1.80 (1.50–2.58) 2.35 (1.50–3.05) 0.2
Preoperative Imaging (any) 38 (86%) 38 (84%) 1.0
Preoperative neck ultrasound 33 (75%) 30 (67%) 0.49
Number of Lymph Nodes Removed, median (range) 4 (0–10) 24 (8–64) <0.001
Number of Positive Lymph Nodes, median (range) 0 (0–5) 2 (0–41) 0.004
Ct pre-op 1142 (581–3472) 1058 (567–5018) >0.9
CEA pre-op 25 (15–103) 35 (14–93) 0.8
Ct post-op 16 (2–176) 16 (3–75) 0.9
CEA post-op 6 (2–9) 5 (2–17) 0.5
Persistent Biochemical Disease 26 (59%) 22 (49%) 0.5
Surgical Era 0.94
 1986–1996 3 (7%) 2 (4%)
 1997–2007 16 (36%) 16 (36%)
 2008–2018 25 (57%) 27 (60%)